No Data
No Data
CARGO Therapeutics Price Target Announced at $33.00/Share by HC Wainwright & Co.
CARGO Therapeutics Price Target Announced at $33.00/Share by HC Wainwright & Co.
H.C. Wainwright Initiates CARGO Therapeutics(CRGX.US) With Buy Rating, Announces Target Price $33
H.C. Wainwright analyst Robert Burns initiates coverage on $CARGO Therapeutics(CRGX.US)$ with a buy rating, and sets the target price at $33.According to TipRanks data, the analyst has a success
Express News | CARGO Therapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
Ongoing Phase 1 study informed dose selection for CARGO's currently enrolling, potentially pivotal Phase 2 clinical study, FIRCE-1 of firicabtagene autoleucel (firi-cel)1, in patients with relapsed or refractory (R/R)
Cargo Therapeutics Shares Rise on Sublease Deal With Vaxcyte
By Sabela Ojea Shares of Cargo Therapeutics rose 6.1% in post-market trading after the company entered a sublease agreement with Vaxcyte. The stock recently traded at $16.97. Shares are down about 31%
CARGO Therapeutics Price Target Announced at $28.00/Share by Chardan Capital
CARGO Therapeutics Price Target Announced at $28.00/Share by Chardan Capital
No Data